Literature DB >> 29257742

A pilot study of the responsiveness of the Neurogenic Bladder Symptom Score (NBSS).

Blayne Welk1, Kevin Carlson2, Richard Baverstock2.   

Abstract

Year:  2017        PMID： 29257742      PMCID： PMC5962943          DOI： 10.5489/cuaj.4833

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  8 in total

1.  On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation.

Authors:  C B Terwee; F W Dekker; W M Wiersinga; M F Prummel; P M M Bossuyt
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

2.  Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders.

Authors:  D E Beaton; S Hogg-Johnson; C Bombardier
Journal:  J Clin Epidemiol       Date:  1997-01       Impact factor: 6.437

Review 3.  Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature.

Authors:  Darshan P Patel; Sean P Elliott; John T Stoffel; William O Brant; James M Hotaling; Jeremy B Myers
Journal:  Neurourol Urodyn       Date:  2014-10-18       Impact factor: 2.696

4.  Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen.

Authors:  Véronique Bonniaud; Dianne Bryant; Bernard Parratte; Gordon Guyatt
Journal:  J Urol       Date:  2008-10-31       Impact factor: 7.450

Review 5.  Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.

Authors:  Gilles Karsenty; Pierre Denys; Gérard Amarenco; Marianne De Seze; Xavier Gamé; François Haab; Jacques Kerdraon; Brigitte Perrouin-Verbe; Alain Ruffion; Christian Saussine; Jean-Marc Soler; Brigitte Schurch; Emmanuel Chartier-Kastler
Journal:  Eur Urol       Date:  2007-10-16       Impact factor: 20.096

6.  The validity and reliability of the neurogenic bladder symptom score.

Authors:  Blayne Welk; Sarah Morrow; Wendy Madarasz; Richard Baverstock; Jennifer Macnab; Keith Sequeira
Journal:  J Urol       Date:  2014-02-08       Impact factor: 7.450

7.  Effect sizes for interpreting changes in health status.

Authors:  L E Kazis; J J Anderson; R F Meenan
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

Review 8.  Not all neurogenic bladders are the same: a proposal for a new neurogenic bladder classification system.

Authors:  Charles R Powell
Journal:  Transl Androl Urol       Date:  2016-02
  8 in total
  3 in total

Review 1.  Recommendations for evaluation of neurogenic bladder and bowel dysfunction after spinal cord injury and/or disease.

Authors:  Denise G Tate; Tracey Wheeler; Giulia I Lane; Martin Forchheimer; Kim D Anderson; Fin Biering-Sorensen; Anne P Cameron; Bruno Gallo Santacruz; Lyn B Jakeman; Michael J Kennelly; Steve Kirshblum; Andrei Krassioukov; Klaus Krogh; M J Mulcahey; Vanessa K Noonan; Gianna M Rodriguez; Ann M Spungen; David Tulsky; Marcel W Post
Journal:  J Spinal Cord Med       Date:  2020-03       Impact factor: 1.985

2.  Cross-cultural adaptation and validation of the neurogenic bladder symptom score questionnaire for Brazilian Portuguese.

Authors:  Lisley Keller Liidtke Cintra; José de Bessa; Victor Ikky Kawahara; Thereza Phitoe Abe Ferreira; Miguel Srougi; Linamara Rizzo Battistella; Daniel Rubio de Souza; Homero Bruschini; Cristiano Mendes Gomes
Journal:  Int Braz J Urol       Date:  2019 May-Jun       Impact factor: 1.541

3.  Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan-A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study).

Authors:  Chung-Cheng Wang; Eric Chieh-Lung Chou; Yao-Chi Chuang; Chih-Chieh Lin; Yu-Chao Hsu; Chun-Hou Liao; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2021-12-20       Impact factor: 4.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.